首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cell chemical biology

缩写:CELL CHEM BIOL

ISSN:2451-9456

e-ISSN:2451-9448

IF/分区:7.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1636
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lyn H Jones Lyn H Jones
In this issue of Cell Chemical Biology, Olson et al. (2019) develop the first selective CDK7 irreversible inhibitor. Elegant cell-based studies using a CDK7 mutant that is not covalently engaged by the probe helped decipher the effects of i...
Haoxin Li,Maria Ericsson,Bokang Rabasha et al. Haoxin Li et al.
The proteinaceous extracellular matrix (ECM) is vital for the survival, proliferation, migration, and differentiation of many types of cancer. However, little is known regarding metabolic pathways required for ECM secretion. By using an unb...
Michael Maurer,Daniela Linder,Kamila B Franke et al. Michael Maurer et al.
ATP-driven bacterial AAA+ proteases have been recognized as drug targets. They possess an AAA+ protein (e.g., ClpC), which threads substrate proteins into an associated peptidase (e.g., ClpP). ATPase activity and substrate selection of AAA+...
Gaelle G Makafe,Muzammal Hussain,Goverdhan Surineni et al. Gaelle G Makafe et al.
There is a great need for identification and development of new anti-tuberculosis drugs with novel targets. Recent drug-discovery efforts typically focus on identifying inhibitors but not activators that perturb metabolic enzymes' functions...
Yujie Huang,Jiansong Fang,Weiqiang Lu et al. Yujie Huang et al.
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease that lacks clinically actionable genetic alterations that limit targeted therapies. Here we explore a systems pharmacology approach that integrates drug-target ...
Marc Hafner,Caitlin E Mills,Kartik Subramanian et al. Marc Hafner et al.
The target profiles of many drugs are established early in their development and are not systematically revisited at the time of FDA approval. Thus, it is often unclear whether therapeutics with the same nominal targets but different chemic...
Ljiljana Sjekloća,Adrian R Ferré-D&#x;Amaré Ljiljana Sjekloća
Thioflavin T (ThT) is widely used for the detection of amyloids. Many unrelated DNAs and RNAs that contain G-quadruplex motifs also bind ThT and strongly activate its fluorescence. To elucidate the structural basis of ThT binding to G quadr...
Jin H Song,Hyun-Jin Kang,Libia A Luevano et al. Jin H Song et al.
Increased telomerase activity is associated with malignancy and poor prognosis in human cancer, but the development of targeted agents has not yet provided clinical benefit. Here we report that, instead of targeting the telomerase enzyme di...
Joe S Matarlo,Lauren R H Krumpe,William F Heinz et al. Joe S Matarlo et al.
Identification of RNA-interacting pharmacophores could provide chemical probes and, potentially, small molecules for RNA-based therapeutics. Using a high-throughput differential scanning fluorimetry assay, we identified small-molecule natur...
Guillermo Banuelos-Sanchez,Laura Sanchez,Maria Benitez-Guijarro et al. Guillermo Banuelos-Sanchez et al.
Retrotransposons are a type of transposable element (TE) that have amplified to astonishing numbers in mammalian genomes, comprising more than a third of the human and mouse genomes. Long interspersed element class 1 (LINE-1 or L1) retrotra...